# A Global, Integrated, Personalized, Stage-related, Multimodal Therapeutic Approach for Rectal Adenocarcinoma Based on Organ Sparing and Mininvasivity

> **NCT06952101** · NA · RECRUITING · sponsor: **Fondazione del Piemonte per l'Oncologia** · enrollment: 200 (estimated)

## Conditions studied

- Rectal Adenocarcinoma
- Non Metastatic

## Interventions

- **PROCEDURE:** Sparing Approach
- **PROCEDURE:** experimental chemoradiotherapy
- **PROCEDURE:** Standard Chemotherapy

## Key facts

- **NCT ID:** NCT06952101
- **Lead sponsor:** Fondazione del Piemonte per l'Oncologia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-30
- **Primary completion:** 2026-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06952101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06952101, "A Global, Integrated, Personalized, Stage-related, Multimodal Therapeutic Approach for Rectal Adenocarcinoma Based on Organ Sparing and Mininvasivity". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT06952101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*